Have a look at a handful of the 50 events that took place during Baltimore Innovation Week 2013. Get involved with Baltimore Innovation Week 2014 here: http://baltimoreinnovationweek.com
The University of Maryland on Wednesday announced the appointment of Thomas R. Fuerst, Ph.D., as the new director of the Institute for Bioscience and Biotechnology Research.
IBBR is a joint research enterprise created to enhance collaboration among the University of Maryland, College Park (UMD), the University of Maryland, Baltimore (UMB), and the National Institute of Standards and Technology (NIST) in the fields of medicine, biosciences, technology, quantitative sciences and engineering.
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
NIH Guide Notice:
Requests for Applications (RFAs):
This NIH Funding Opportunity Announcement (FOA) invites applications to support an Evaluation and Administration Coordinating Center. This unit will facilitate the coordination among and between the awardees of RFA-HL-14-019 “Low-Cost, Pragmatic, Patient-Centered Randomized Controlled Intervention Trials (UH2/UH3)” and the NIH. This unit will also be responsible for conducting an evaluation of the RFA-HL-14-019 program.
This NIH Funding Opportunity Announcement (FOA) invites applications to plan and conduct low-cost, pragmatic randomized controlled trials (RCTs).
Using scores obtained from cognitive tests, Johns Hopkins researchers think they have developed a model that could help determine whether memory loss in older adults is benign or a stop on the way to Alzheimer’s disease.
The risk of developing dementia increases markedly when a person is diagnosed with mild cognitive impairment, a noticeable and measurable decline in intellectual abilities that does not seriously interfere with daily life. But physicians have no reliable way to predict which people with mild cognitive impairment are likely to be in the 5 to 10 percent a year who progress to dementia.
An earlier research brief we’d issued highlighted that Silicon Valley dominates the list of top 50 VC-backed tech exits. The post generated a fair amount of chatter including some comments calling us arrogant Silicon Valley’ites (we’re based in NYC).
Among the more constructive comments were several from healthcare VCs who wondered if the data would be similar for the healthcare sector. The prevailing hypothesis was that Silicon Valley’s dominance wouldn’t translate to healthcare (or perhaps not as much). Note: our healthcare classification includes companies ranging from medical devices to biotech to pharma.
Investor Barbara Corcoran said that she has learned to spot the red flags of “well-intended misrepresentations” and fancy talk during her four seasons judging startups on Shark Tank.
Corcoran talked with Henry Blogett of Business Insider about how many companies she has invested in — about 25 — and how many have worked. Here is how she evaluated the four seasons:
Billlionaire investor Mark Cuban, who owns the Dallas Mavericks and Landmark Theaters and is a regular on Shark Tank, has expanded his interests to personalized health. He is part of a group of investors in mobile health startup, Validic,which raised $760,000 in a seed round. The Durham, North Carolina company has developed a platform to integrate and aggregate data from more than 80 health-oriented apps.
Cuban said this about the investment:
“Personalized health is the future of healthcare…and with the explosive growth of new mobile apps and devices coming on the market, Validic solves a fundamental problem of integrating all those new innovations into the healthcare system. I’m very excited for the future of Validic and the mobile health space.”
Mary Washington Healthcare (MWHC) and Zebrareach today announced a collaboration that provides MWHC’s more than 4,000 Associates free membership to Zebrareach, a smartphone application that gives employees loyalty discounts at local stores, as well as other special offers negotiated for MWHC. The Zebrareach membership program for MWHC will launch in November 2013.
Zebrareach (http://zebrareach.com) is a mobile customer engagement application for small business that builds customer retention through a free consumer smartphone application. Businesses build and manage volume and tier-based loyalty programs, message exclusive news, product announcements, special events, secret menu items, limited time offers and more to their loyal customers. Customers are able to place orders for products and services through the web and mobile Zebrareach application. Zebrareach works for all customers, with or without mobile phones.
The Indian Biomedical Association (IBA) is inviting entrepreneurs from early phase companies with products or services in the life sciences industry the opportunity to connect, collaborate and partner with investors.
Entrepreneurs should submit their presentations for IBA’s event on “Developing and delivering effective investor presentation for your early stage venture” by 10/31/2013 for the event to be held on Tue November 19, 2013, 6:00 – 8:00 PM. Location: Johns Hopkins University, Room 121, Building 3, 9605 Medical Center Dr, Rockville, MD.20850
Selected companies will be invited to make their pitch to a panel of experts who will provide critical feedback.
Following the above event, a short list of selected companies will be invited to make their presentation to a group of investors on Tue December 17, 2013, 6:00 – 8:00 PM, at IBA’s “Biomedical Innovation Funding Forum“. Location: Johns Hopkins University, Room 121, Building 3, 9605 Medical Center Dr, Rockville, MD, 20850